Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021

SELL
$83.5 - $98.47 $1.95 Million - $2.3 Million
-23,334 Closed
0 $0
Q3 2020

Oct 13, 2020

SELL
$82.14 - $91.0 $4,928 - $5,460
-60 Reduced 0.26%
23,334 $2.03 Million
Q1 2020

Apr 21, 2020

SELL
$70.67 - $99.01 $30,176 - $42,277
-427 Reduced 1.79%
23,394 $1.93 Million
Q4 2019

Jan 24, 2020

SELL
$84.35 - $95.37 $18,725 - $21,172
-222 Reduced 0.92%
23,821 $2.26 Million
Q3 2019

Oct 15, 2019

BUY
$85.54 - $94.26 $1.47 Million - $1.62 Million
17,202 Added 251.45%
24,043 $2.09 Million
Q1 2019

Apr 11, 2019

SELL
$75.32 - $86.15 $549,836 - $628,895
-7,300 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$73.66 - $82.02 $22,098 - $24,606
300 Added 4.29%
7,300 $561,000
Q3 2018

Oct 25, 2018

BUY
$66.94 - $77.43 $39,494 - $45,683
590 Added 9.2%
7,000 $603,000
Q2 2018

Aug 10, 2018

BUY
$64.91 - $73.36 $18,564 - $20,980
286 Added 4.67%
6,410 $484,000
Q1 2018

Apr 09, 2018

SELL
$70.39 - $84.15 $17,034 - $20,364
-242 Reduced 3.8%
6,124 $495,000
Q4 2017

Jan 24, 2018

SELL
$72.33 - $77.64 $81,371 - $87,345
-1,125 Reduced 15.02%
6,366 $534,000
Q3 2017

Oct 11, 2017

BUY
$74.14 - $77.27 $555,382 - $578,829
7,491
7,491 $643,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ferguson Wellman Capital Management, Inc Portfolio

Follow Ferguson Wellman Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.